Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × MLN 8237 × 90 days × Clear all

Phase

Status

Active not recruiting 2 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Specimen Handling 296 pembrolizumab 260 Magnetic Resonance Spectroscopy 242 Carboplatin 167 Biopsy 159 Cyclophosphamide 143 Cisplatin 139 Paclitaxel 115 Radiotherapy 109 Gemcitabine 104 Bevacizumab 104 Nivolumab 96 venetoclax 95 Dexamethasone 89 fludarabine 86 Fluorouracil 72 Rituximab 71 Oxaliplatin 69 Docetaxel 69 Capecitabine 68 Drug Therapy 67 Pemetrexed 65 Standard of Care 63 Radiosurgery 61 durvalumab 59 atezolizumab 58 Radiation 58 Injections 57 X-Rays 56 Leucovorin 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06095505 2026-02-17

ALISCA-Lung1

Puma Biotechnology, Inc.

Phase 2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡